Skip to main content
. 2019 Nov 27;19:334. doi: 10.1186/s12906-019-2675-5

Table 3.

Skin-transport parameter obtained for various test formulations (Mean ± SD)

Formulation Flux (μg /cm− 2 h− 1) PC0 × 10–3 a Cumulative drug skin-permeation (%) Amount retained in skin (μg/cm2)
TQ EV 11.25 ± 1.05 15.78 ± 2.01 36.62 ± 2.01 88.71 ± 3.02
TQ suspension 1.08 ± 0.01 8.00 ± 1.01 11.60 ± 1.07 72.86 ± 3.01

a PC0: Permeability coefficient